A
Amanda C. Cohn
Researcher at National Center for Immunization and Respiratory Diseases
Publications - 69
Citations - 8019
Amanda C. Cohn is an academic researcher from National Center for Immunization and Respiratory Diseases. The author has contributed to research in topics: Vaccination & Meningococcal disease. The author has an hindex of 29, co-authored 66 publications receiving 6668 citations. Previous affiliations of Amanda C. Cohn include Centers for Disease Control and Prevention.
Papers
More filters
Journal ArticleDOI
First Case of 2019 Novel Coronavirus in the United States.
Michelle Holshue,Chas DeBolt,Scott Lindquist,Kathy H Lofy,John Wiesman,Hollianne Bruce,Christopher Spitters,Keith M. Marzilli Ericson,Sara Wilkerson,Ahmet Tural,George Diaz,Amanda C. Cohn,LeAnne Fox,Anita Patel,Susan I. Gerber,Lindsay Kim,Suxiang Tong,Xiaoyan Lu,Steve Lindstrom,Mark A. Pallansch,William C. Weldon,Holly M. Biggs,Timothy M. Uyeki,Satish K. Pillai +23 more
TL;DR: This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.
Journal ArticleDOI
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.
Amanda C. Cohn,Jessica R. MacNeil,Lee H. Harrison,Cynthia Hatcher,Jordan Theodore,Mark Schmidt,Tracy Pondo,Kathryn E. Arnold,Joan Baumbach,Nancy M. Bennett,Allen S. Craig,Monica M. Farley,Ken Gershman,Susan Petit,Ruth Lynfield,Arthur Reingold,William Schaffner,Kathleen A. Shutt,Elizabeth R. Zell,Leonard W. Mayer,Thomas A. Clark,David S. Stephens,Nancy E. Messonnier +22 more
TL;DR: Before the introduction of the quadrivalent meningococcal conjugate vaccine, the incidence of meningitis disease in the United States decreased to a historic low, however, mening bacteria still causes a substantial burden of disease among all age groups.
Journal Article
National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009.
TL;DR: For example, the National Immunization Survey-Teen (NIS-Teen) has been used to estimate vaccination coverage from a national sample of adolescents aged 13-17 years as discussed by the authors.
Journal ArticleDOI
Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020.
Margaret A. Honein,Athalia Christie,Dale A. Rose,John T. Brooks,Dana Meaney-Delman,Amanda C. Cohn,Erin K. Sauber-Schatz,Allison Taylor Walker,L. Clifford McDonald,Leandris C. Liburd,Jeffrey E. Hall,Alicia M. Fry,Aron J. Hall,Neil Gupta,Wendi L. Kuhnert,Paula W. Yoon,Adi V. Gundlapalli,Michael J. Beach,Henry Walke +18 more
TL;DR: Individual persons, households, and communities should take these actions now to reduce SARS-CoV-2 transmission from its current high level and provide a bridge to a future with wide availability and high community coverage of effective vaccines.
Journal ArticleDOI
Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008.
Jessica R. MacNeil,Amanda C. Cohn,Monica M. Farley,Raydel Mair,Joan Baumbach,Nancy M. Bennett,Ken Gershman,Lee H. Harrison,Ruth Lynfield,Susan Petit,Arthur Reingold,William Schaffner,Ann Thomas,Fatima Coronado,Elizabeth R. Zell,Leonard W. Mayer,Thomas A. Clark,Nancy E. Messonnier +17 more
TL;DR: There is no evidence of substantial replacement disease with non-b serotypes in young children in the United States after the introduction of Hib conjugate vaccines, but a considerable burden of non-Hib disease is still present in the oldest and youngest age groups.